ETUDE DEVELOPPEMENT INJECTION PLASTIQUE : revenue, balance sheet and financial ratios

ETUDE DEVELOPPEMENT INJECTION PLASTIQUE is a French company founded 19 years ago, specialized in the sector Fabrication de pièces techniques à base de matières plastiques. Based in MARCILLE-LA-VILLE (53440), this company of category ETI shows in 2024 a revenue of 60 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ETUDE DEVELOPPEMENT INJECTION PLASTIQUE (SIREN 491293494)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 60 000 € 914 373 € 3 246 665 € 4 414 065 € 3 722 116 € 5 789 848 € 5 407 374 € 5 021 546 € 4 782 452 €
Net income 62 015 € 27 588 € -134 259 € -29 923 € -279 697 € 219 239 € 590 253 € 385 046 € 379 059 €
EBITDA 58 344 € 15 299 € -106 880 € 242 577 € -371 430 € 465 205 € 751 485 € 609 996 € 526 427 €
Net margin 103.4% 3.0% -4.1% -0.7% -7.5% 3.8% 10.9% 7.7% 7.9%

Revenue and income statement

In 2024, ETUDE DEVELOPPEMENT INJECTION PLASTIQUE achieves revenue of 60 k€. Revenue is declining over the period 2016-2024 (CAGR: -42.1%). Significant drop of -93% vs 2023. After deducting consumption (0 €), gross margin stands at 60 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 58 k€, representing 97.2% of revenue. Positive scissor effect: EBITDA margin improves by +95.6 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 62 k€, i.e. 103.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

60 000 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

60 000 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

58 344 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

9 560 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

62 015 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

77.3%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 54%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 4.5 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 134.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

53.862%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

63.391%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

133.981%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

4.533

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

6.7%

Solvency indicators evolution
ETUDE DEVELOPPEMENT INJECTION PLASTIQUE

Sector positioning

Debt ratio
53.86 2024
2022
2023
2024
Q1: 7.54
Med: 27.74
Q3: 63.65
Average -7 pts over 3 years

In 2024, the debt ratio of ETUDE DEVELOPPEMENT INJEC... (53.86) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
63.39% 2024
2022
2023
2024
Q1: 30.63%
Med: 49.0%
Q3: 65.86%
Good +38 pts over 3 years

In 2024, the financial autonomy of ETUDE DEVELOPPEMENT INJEC... (63.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
4.53 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.78 years
Q3: 2.44 years
Average +50 pts over 3 years

In 2024, the repayment capacity of ETUDE DEVELOPPEMENT INJEC... (4.53) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 3793.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 15.8x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

3793.597

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

15.841

Liquidity indicators evolution
ETUDE DEVELOPPEMENT INJECTION PLASTIQUE

Sector positioning

Liquidity ratio
3793.6 2024
2022
2023
2024
Q1: 173.28
Med: 264.79
Q3: 378.42
Excellent +7 pts over 3 years

In 2024, the liquidity ratio of ETUDE DEVELOPPEMENT INJEC... (3793.60) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
15.84x 2024
2022
2023
2024
Q1: 0.0x
Med: 2.4x
Q3: 11.98x
Excellent +50 pts over 3 years

In 2024, the interest coverage of ETUDE DEVELOPPEMENT INJEC... (15.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 1217 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 944 days. The gap of 273 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 7114 days of revenue, i.e. 1.2 M€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

1 185 613 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

1217 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

944 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

7114 j

WCR and payment terms evolution
ETUDE DEVELOPPEMENT INJECTION PLASTIQUE

Positioning of ETUDE DEVELOPPEMENT INJECTION PLASTIQUE in its sector

Comparison with sector Fabrication de pièces techniques à base de matières plastiques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (46 transactions). This range of 23 788€ to 169 757€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
23k€ 82k€ 169k€
82 843 € Range: 23 788€ - 169 757€
NAF 5 all-time
How is this estimate calculated?

This estimate is based on the analysis of 46 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de pièces techniques à base de matières plastiques)

Compare ETUDE DEVELOPPEMENT INJECTION PLASTIQUE with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de pièces techniques à base de matières plastiques

Frequently asked questions about ETUDE DEVELOPPEMENT INJECTION PLASTIQUE

What is the revenue of ETUDE DEVELOPPEMENT INJECTION PLASTIQUE ?

The revenue of ETUDE DEVELOPPEMENT INJECTION PLASTIQUE in 2024 is 60 k€.

Is ETUDE DEVELOPPEMENT INJECTION PLASTIQUE profitable?

Yes, ETUDE DEVELOPPEMENT INJECTION PLASTIQUE generated a net profit of 62 k€ in 2024.

Where is the headquarters of ETUDE DEVELOPPEMENT INJECTION PLASTIQUE ?

The headquarters of ETUDE DEVELOPPEMENT INJECTION PLASTIQUE is located in MARCILLE-LA-VILLE (53440), in the department Mayenne.

Where to find the tax return of ETUDE DEVELOPPEMENT INJECTION PLASTIQUE ?

The tax return of ETUDE DEVELOPPEMENT INJECTION PLASTIQUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ETUDE DEVELOPPEMENT INJECTION PLASTIQUE operate?

ETUDE DEVELOPPEMENT INJECTION PLASTIQUE operates in the sector Fabrication de pièces techniques à base de matières plastiques (NAF code 22.29A). See the 'Sector positioning' section above to compare the company with its competitors.